RSNN workshop 2020 'Leveraging the value of collaboration - from regulatory science to regulatory innovation'
In this RSNN workshop key regulatory science questions in the coming years will be explored, and it will be especially addressed how collaborative research can be of most value for regulators, patients, companies, HTA bodies, academia and other stakeholders. Discussions with the audience, representing various backgrounds are a critical element in this respect.
In the first part of the workshop, Tony Humpreys (European Medicines Agency), Marjon Pasmooij (CBG-MEB) and Jarno Hoekman (Utrecht University) will share their point of view on the main theme. In the second part, 15-minute presentations will be given by a number of speakers on recent regulatory science case studies, with special attention to key success factors.
- Date: Wednesday 8 April 2020, 13:00-17:30 followed by networking drinks (+ dinner)
- Location: Villa Jongerius, Utrecht
- Registration: Free of charge
- Target audience: Experts from EMA, academia, (bio)pharmaceutical industry, patient communities, regulatory authorities and the medical profession
Registration for the RSNN workshop on April 8th "Leveraging the value of collaboration - from regulatory science to regulatory innovation" is now open.
1st Dutch Antisense Therapeutics Symposium (DATS)
On 19 June 2020 the first Dutch Antisense Therapeutics Symposium is held at the LUMC in Leiden. The aim of this symposium is to strengthen the oligo research in the Netherlands, increase collaborations, and allow young researchers to network and present their results on oligo research.
Prof. Annemieke Aartsma-Rus from the LUMC and Dr. Bruno Godinho from the University of Massachusetts, who are major contributors to the field of antisense therapeutics, will be keynote speakers.
You can register for this meeting via the Dutch Antisense website. The website also provides the full program for the day. Abstracts can be submitted (deadline 1 May 2020) by filling in the standard format provided on the website and mailing it to email@example.com.
DIA Regulatory Science Forum
On 29 and 30 September, 2020 the DIA is organising for the first time, the Regulatory Science Forum. It is envisioned that this Regulatory Science Forum is a platform for sharing knowledge derived from regulatory science research and analyses conducted at the academic, industry and regulatory levels, promoting an open dialogue between all stakeholders. The Forum will discuss where more research is needed, as well as the best ways to promote the widespread implementation of findings, recommendations, and other results.
More information can be found on the DIA website. The DIA is a global association that mobilises life science professionals from industry, payers, patients and regulators together in a neutral forum to discuss current issues regarding drug development.
The call for Abstracts has been opened. The deadline is 13 March 2020. Submit your abstracts here.